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The study proposal was to evaluate the pharmaceutical assistance in the state of Minas Gerais (MG) 
utilizing pharmaceutical assistance indicators described in the literature. The evaluated items were: 
organization, financing, selection, acquisition, programming, distribution, availability and storage of 
medicines in 18 municipalities of the Regional Management of Health of Belo Horizonte. The results have 
shown good performance respecting service organization, presence and updating of Municipal Essential 
Drug List. The main problems were related to stock control and availability of some items. The work 
has demonstrated the operational viability of indicators, as to evaluate the conditions of pharmaceutical 
assistance, as to monitor their performance.
Uniterms: Pharmaceutical assistance. Health services/evaluation. 
A proposta do estudo foi avaliar a assistência farmacêutica no estado de Minas Gerais (MG), utilizando 
indicadores da assistência farmacêutica descritos na literatura. Os itens avaliados foram: organização, 
financiamento, seleção, aquisição, programação, distribuição, disponibilidade e armazenamento de 
medicamentos em 18 municípios da Gerência Regional de Saúde de Belo Horizonte. Os resultados 
mostraram bom desempenho quanto à organização do serviço, presença e atualização da Relação 
Municipal de Medicamentos. Os principais problemas foram em relação ao controle de estoque e 
disponibilidade de alguns itens. O trabalho demonstrou a viabilidade operacional dos indicadores, tanto 
para avaliar as condições dos serviços farmacêuticos, quanto para monitorar seu desempenho.
Unitermos: Assistência farmacêutica. Serviços de saúde/avaliação.
INTRODUCTION
The institutionalization of the Unified Health System 
(Sistema Único de Saúde – SUS) has drastically changed 
the model of Brazilian health system. From the organiza-
tional point of view, the main change was the decentraliza-
tion of services with a single direction in every government 
sphere and emphasis in the municipalization of actions. 
As a matter of fact, along the process, the responsibilities, 
attributions and resources in health have passed to be more 
and more shared by the state and municipal spheres. This 
logic considers the municipality as the more adequate 
governmental entity to treat the health issue, because it 
is closer to population (Barata et al., 2004). The health 
services under responsibility of local administrations were 
amplified and diversified, among them the pharmaceutical 
assistance (PA), which is defined in the National Medi-
cines Policy (Política Nacional de Medicamentos - PNM) 
as a “group of activities related with medications, destined 
to support the health actions demanded by a community” 
(Brasil, 1998).
The theoretical construction of PA and its organization 
proposals seek the expansion of access and the promotion 
of rational use of medicines. Its arrangement is grounded 
in the basic principles of SUS, mainly in the strategy of 
management decentralization. The first effective step was 
the institution, in 1999, of the Incentive to Basic Pharma-
ceutical Assistance (Incentivo à Assistência Farmacêutica 
Básica – IAFB) (Brasil, 1998), establishing the mutual 
financial responsibility between the three levels of gover-
nment, which has promoted a progressive autonomy to 
states and municipalities for the management of financial 
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resources. The criteria for qualification to IAFB have inclu-
ded the elaboration of a State Plan of Basic Pharmaceutical 
Assistance (Plano Estadual de Assistência Farmacêutica 
Básica), which should make explicit the list of essential 
drugs as well as the systematic for programming, following-
up, controlling, and evaluation of its implementation. In 
view of this reorientation, the State Secretariat of Health 
of Minas Gerais (Secretaria de Estado de Saúde de Minas 
Gerais – SES/MG), by means of the Coordination of Basic 
Pharmaceutical Service (Coordenadoria de Assistência 
Farmacêutica Básica – CAF), has installed in 2003 the 
Programa Farmácia de Minas (PFM). Complementary to 
other state initiative, the PFM has as one of its fundamental 
axis the “subsidy to municipalities for the organization and 
implementation of pharmaceutical assistance” in order to 
promote their “amplification of managerial capacity” (Su-
perintendência, 2003, 2004). 
The importance of PA for the healthcare, its conso-
lidation and improvement in the municipalities imposes 
the necessity of strategies to follow-up the performance of 
this activity. So, the objective of this study was to evaluate 
the pharmaceutical assistance in municipalities in the state 
of Minas Gerais (MG). 
MATERIAL AND METHODS
A transversal study based on the application of a roll 
of indicators destined to evaluate the pharmaceutical assis-
tance was conducted. The indicators utilized were based on 
those presented by the World Health Organization - WHO 
(WHO, 1999, 2003). The study of Cosendey (2000) and 
the indicators of Management Sciences for Health – MSH 
(MSH, 1995) were also utilized. The indicators proposed 
by Cosendey were particularly important, because they 
reflect better the national reality. The data were collected 
in structured questionnaires and interview, along with 
consultation to administrative databases.
The study was developed in the current Regional 
Health Administration (Gerência Regional de Saúde – 
GRS) of Belo Horizonte, constituted by 39 municipalities 
distributed as follows: 26 (67%) small municipalities (up 
to 50 thousand inhabitants); nine (23%) medium sized 
municipalities (from 50 to 300 thousand inhabitants) and 
four (10%) large municipalities (above 300 thousand inha-
bitants). The choice of this GRS was done by convenience, 
taking into account the cost and technical-operational 
aspects. The choice also took into account the fact that the 
region has a great proportion of state population, has both 
large and small cities (with a great variety in their organi-
zational complexity), besides its political and economic 
relevance, which together gives the region representati-
veness in terms of population and as a diffuser source of 
new trends in healthcare. 
The number of municipalities has targeted a sample 
close to 50% of the total number of municipalities, privi-
leging in proportional terms the two population ranges 
with lower number of inhabitants, because of their higher 
population representativeness. The selection of municipa-
lities took place at random, in every of the three specified 
ranges. The interviews for data collection were developed 
with the pharmacists who were responsible for the PA 
coordination in the municipalities. Data were collected in 
the local distribution center (a municipal health facility 
where drugs are stored) and in two health drug dispensing 
facilities (Unidades de Saúde – US). In one of the selected 
municipalities, there was only one US. So, the sample was 
constituted by 18 distribution centers and 35 US.
The PA coordinators of the municipalities were con-
tacted to schedule the interviews. During the initial con-
tact, done by phone, it was detailed the research purpose 
and formalized the invitation for participation.
In the municipalities, the data were collected from 
three sources: interviews with PA coordinators, in loco 
observation, and records consultation in the units. In 
order to characterize the organizational structure of PA, 
interviews were developed with the people responsible for 
such activity in the municipality. The municipalities pre-
senting pharmaceutical assistance in the organization chart 
of the Municipal Secretariat of Health, and having also a 
Municipal Plan of Pharmaceutical Assistance, were consi-
dered as presenting an organized PA sector. The financing 
data were collected in the System of Information about 
Public Budgets in Health (Sistema de Informações sobre 
Orçamentos Públicos em Saúde – SIOPS), which was 
made available by DATASUS*. A copy of the Municipal 
Essential Drugs List (Relação Municipal de Medicamentos 
– REMUME) was evaluated. If the list (or its update) was 
more recent than three years, the municipality was clas-
sified as having an updated REMUME. Data about drug 
acquisition were obtained directly from the interviewed 
people, by requesting them to the purchases department in 
the municipalities, and by means of consultation to SIOPS. 
For evaluation of the inventory control, the actual stock 
in the distribution center, collected by local count, was 
confronted with the stock registered in the control system 
(computerized or paper-based). 
Actual physical stocks of 20 key drugs were counted. 
The key drugs list was selected from the State Essential 
* http://w3.datasus.gov.br/datasus/datasus.php
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Drug List: acetylsalicylic acid 100 mg tablet; amoxicillin 
500 mg tablet; amoxicillin 50 mg/ml powder for suspen-
sion; benzathine benzylpenicillin 1.200.000 UI; cimetidi-
ne 200 mg tablet; diazepam 10 mg tablet; erythromycin 
250 mg tablet; erythromycin 25 mg/mL suspension; gli-
benclamide 5 mg tablet; hydrochlorothiazide 50 mg tablet; 
imipramine 25 mg coated tablet; mebendazole 20 mg/mL 
tablet; metronidazole 250 mg tablet; paracetamol 500 mg 
tablet; propranolol 40 mg tablet; oral rehydration salts 
powder envelope; salbutamol 0,4 mg/mL oral solution; 
sulphamethoxazole + trimethoprim 400 + 80 mg tablet; 
sulphamethoxazole + trimethoprim 4% + 0,8 suspension; 
ferrous sulphate 25 mg Fe/mL oral solution. This list was 
defined as a parameter for the evaluation of inventory 
accuracy and availability of essential drugs, based on the 
presupposition that such drugs should be continuously 
available in the US. The count values were compared to 
those recorded in the paper-based or computerized inven-
tory control system. The records presenting a variation of 
more or less than 5% respecting to physical count were 
considered as accordant. The obtained result was catego-
rized as follows: up to 50% of accordant items – classified 
as bad; from 50% to 75% – classified as reasonable; and 
above 75% of accordant items – classified as good.
Programming and distribution components of phar-
maceutical assistance chain were analyzed conjunctively, 
by means of the immediate availability of drugs being 
verified in the visited local distribution center and US. 
This information reflects the programming effectiveness 
in the municipality, by means of the availability of the key 
drugs in the distribution center and US. Yet respecting 
to distribution, it was investigated the proportion of key 
drugs appearing in the municipal distribution center stock 
and available in the US. Such information could point 
out the efficiency of the distribution strategy adopted in 
the municipalities, as it is expected that, with a minimal 
variation, the drug present in the distribution center, must 
be present also in the US.
Complementary data respecting the health situation 
in the municipalities were obtained from secondary data-
bases made available by the Ministry of Health.
Data collected were placed in a Microsoft Access® 
database. The analysis, expressed in terms of tables of 
simple frequency distribution and graphics, was done in 
Microsoft Excel®.
ETHICAL CONSIDERATIONS
The project has neither an intervention over human 
subjects, nor used personal information. Even though peo-
ple were responsible for providing information, they were 
sought as professionals who were responsible for specific 
sectors, and all questionings were limited to institutional 
information. So, it was understood that there were no reason 
for analysis by an ethics committee, but only for the discre-
tion from the competent instance of SUS, in order to autho-
rize the research. After this authorization, all interviewed 
people received a presentation letter and an invitation for 
volunteer participation. They were informed about the study 
objectives, and the collection instruments were applied only 
in establishments where the PA responsible had previously 
verbally consented. It was explained that data would be 
presented aggregately, without any identification of the 
interviewed person, municipality, or establishment.
RESULTS AND DISCUSSION
The visits were done between November, 25th and 
December, 28th of 2005. All sampled municipalities were 
visited. Demographic and health financing data from 
these municipalities are presented at Table I. One of the 
18 distribution centers could not be visited, because of 
a coincidence between the date scheduled for visit and 
the local inventory period. In two of the 35 selected US, 
the person responsible for information was not found. 
The main difficulties related to information availability 
occurred with data about drug acquisition, and this item 
presented the lower index of response within the indicators 
group, with 39%. Notwithstanding the field operational 
difficulties, and the low index of responses in the item 
of drug acquisition, the selected indicators and the data 
collection process related to them have shown viability, 
and the grade of responses to the research was satisfactory.
Table II resumes the main results, showing the 
average, the lower and the higher value found for every 
of the indicators. The data of this table, in the sub-items 
A (financing); B (sector organization); C (drug selection); 
D (drug acquisition) are referred to information collected 
in the Municipal Secretariats of Health; therefore, they 
have summed as a maximum 18, when the information 
was available in all the municipalities. The same table 
data of sub-item E (storage) are referred to information 
collected in the distribution center and have summed, as a 
maximum, 17, as it was not possible to detect the data from 
one distribution center. Only the data reported at sub-item 
F (programming/distribution) are referred to simultaneous 
information in the distribution center (F.1) and the US, 
completing, therefore, a total of 17 and 33, respectively. 
For the categorical indicators, the data are presented as the 
most frequently found percentage of response.
PA appears formally organized in 44% of the muni-
cipalities. No attempt was made to evaluate the quality of 
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the municipal plans of pharmaceutical assistance, or their 
respective suitability to local realities; the implementa-
tion of these municipal plans was not evaluated, as well. 
However, this is an important subject to be considered 
in further evaluations of pharmaceutical assistance. The 
mean expense with acquisition by means of bidding was 
of 76% of resources, and 84% of the indebted resources 
were effectively expended. The analysis of mechanisms 
of stock control showed that in 35% of local distribution 
centers, the concordance of physical count was considered 
as good (Figure 1), while in 53% of distribution centers 
this concordance was considered as bad. As an average, 
56% of records corresponded, in quantitative terms, to 
actual physical stock.
The availability of drug indicators showed that, as 
an average, 89% of investigated items were present in the 
distribution centers, while the average availability in the 
US was of 74%. These results are detailed at Table III, 
that shows the availability of every of the investigated 
drugs. Sulphamethoxazole + trimethoprim tablet was the 
drug that presented the larger availability in the US (88%), 
while paracetamol 500 mg presented the lower availability 
(58%), together with diazepam 10 mg, imipramine 25 mg 
and the benzathine benzylpenicillin 1.200.00 UI, that were 
available in only 61% of the US. Acetylsalicylic acid 
100 mg, diazepam 10 mg and again sulphamethoxazole + 
trimethoprim tablets were present in all of the investigated 
distribution centers. Other drugs with low availability in 
the distribution centers were the mebendazole suspension 
(77%) and the paracetamol 500 mg, with 65%. The inves-
tigation indicated even that, as an average, 83% of drugs 
found in the local distribution center were also available 
at the US.
The data showed positive results respecting the or-
ganization process in pharmaceutical assistance (Marin et 
al., 2003; Perini, 2003). The majority of municipalities had 
the REMUME approved and within an acceptable period 
of updating. Another positive aspect is referred to the drug 
acquisition mechanism and selection, with a significant 
percent of municipal expenses done by bidding. The 26% 
of expenses done by direct purchase, an acquisition me-
chanism frequently associated to higher cost, demonstrates 
the permanence of a practice that progressively looks to 
be in process of replacement. Even about the acquisition, 
the data showed efficiency in the execution of municipal 
TABLE I – General characteristics of municipalities. Regional Management of Health of Belo Horizonte, MG, 2005.
Indicator Source Year
Characteristics
Municipalities 
sampled
MG Brazil
Number of cities IBGE 2006 36 853 5,5601
Proportion of cities in the study - - - 4.2% 0.6%
Population (estimation) IBGE 2005 4,195,463 19,237,450 184,184,264
Proportion of population in the study - - - 22.4% 2.3%
Proport. pop. older than 60 years (%) IBGE 2003 7.51 10.2 9.5
IDH-M3 PNUD 2000 0.7672 0.773 0.766
Child mortality (/1.000 born alive) MS 2003 17 20 24
Total health expense per inhab. (R$) SIOPS 2004 191.64 98.69 125.5
Medications expense per inhabitant 
(% of total health expense)
SIOPS 2004 4.57 7.63 6.44
1 Datum from 2001, according IBGE (http://www.ibge.gov.br/brasil_em_sintese/default.htm - access on Sep/08/2006)
2 Average of investigated cities
3 Human Development Index - Municipal
FIGURA 1 - Municipalities distribution as a function of the 
percentage of physical stock corresponding to records in their 
stock control instrument. Regional Management of Health of 
Belo Horizonte, MG, 2005.
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TABLE II – Evaluated indicators, data sources, objectives, construction strategies and abstract of results obtained for every of 
investigated indicators respecting management of Pharmaceutical Care. Regional Management of Health of Belo Horizonte, MG, 
2005
Evaluated indicator Source Objective Construction strategy Results
Mean Lower Higher N
A. Financing
A.1. Financial value 
per capita applied in 
medications in the city 
SIOPS1 To evaluate the resources 
availability in the city 
for acquisition of basic 
medications.
Research into public 
databank (sum of 
municipal, state, and 
federal resources)
12.70 0.46 19.56 18
B. Sector organization
B.1. Existence of a 
management in PC2 in 
the SMS3 organizational 
chart
AFM4 Indicate the level of PC 
organization in the city
Interview with the 
coordinator Yes - 50% of cities 18
B.2. Existence of written 
PMAF5.
AFM Indicate the level of PC 
organization in the city
Interview with the 
coordinator Yes - 61% of cities 18
B.3. PC formally 
organized, with 
management in the 
organizational chart of 
SMS and written PMAF.
AFM Indicate the level of PC 
organization in the city
Interview with the 
coordinator
Yes - 44% of cities 18
C. Medications selection
C.1. Existence of 
REMUME6
AFM Evaluate if the city 
develops medication 
selection.
Interview with the 
coordinator Yes - 83% of cities 18
C.2. Last updating of 
REMUME.
AFM Evaluate the periodicity 
of REMUME updating
Interview with the 
coordinator
Less than 3 years – 78% of 
cities 18
C.3. Percentage of 
medications of REM7 
for the APS8 in the 
REMUME.
REMUME
REM
Evaluate the rationality of 
REMUME
Number of items of REM 
in the REMUME / total of 
items of State Recording 
(*100)
95% 70% 100% 10
D. Acquisition 
D.1. Percentage of 
municipal resources for 
medications acquisition 
spent in the modality 
Bidding.
AFM/SMS To know the destination 
of resources for the 
medications purchase in 
the modality Bidding
Expenses with medications 
in bidding / total expenses 
with medications for the 
city. (*100).
76% 0% 100% 7
D.2. Percentage of 
expense paid with 
medications respecting 
indebted expense
SIOPS To evaluate the level 
of financial execution 
respecting to which was 
planned for medications 
acquisition
Expenses paid for the 
medications acquisition / 
Indebted expenses (*100) 84% 33% 100% 18
E. Armazenamento
E.1. Average percentage 
of stock records 
corresponding to 
physical count.
AM To evaluate the 
effectiveness of stock 
control instrument in the 
municipal warehouse.
To count the medications in 
stock and compare it with 
recorded value. Number of 
marker-medications whose 
record in stock corresponds 
to physical count/ total 
number of evaluated 
medications (*100)
56% 5% 100% 17
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Evaluated indicator Source Objective Construction strategy Results
Mean Lower Higher N
F. Programming/Distribution
F.1. Average 
immediate availability 
of medications at 
warehouse.
AM9 To evaluate the 
availability of marker-
medications at warehouse
For every marker-
medication, verify the 
presence at warehouse. 
Number of present items /
total of evaluated items 
(*100)
89% 70% 100% 17
F.2. Average immediate 
availability of 
medications at the 
dispensation place.
US10 To evaluate the 
availability of marker-
medications at the Health 
Units 
For every marker-
medication, verify the 
presence at the Health Unit. 
Number of present items 
/ total of evaluated items 
(*100).
81% 64% 91% 33
F.3. Average percentage 
of medications 
available in the place 
of dispensation and 
appearing also at the 
municipal warehouse 
stock.
US
AM
To evaluate the 
effectiveness of 
distribution strategy 
adopted in the city.
Number of marker-
medications available in 
the Health Unit / number 
of marker-medications 
available in the warehouse 
(*100)
92% 50% 115% 33
1 System of Information about Public Budgets in Health; 2 Pharmaceutical Care; 3 Municipal Secretariat of Health; 4 Basic 
Pharmaceutical Care; 5 Municipal Plan of Pharmaceutical Care; 6 Municipal Recording of Medications; 7 State Recording of 
Medications; 8 Primary Healthcare; 9 Municipal Warehouse; 10 Health Unit
TABLE II – continuation
TABLE III – Availability of key drugs observed in the US, in the local distribution center, and in both, simultaneously. Regional 
Management of Health of Belo Horizonte, MG, 2005
Medication Availability
US Warehouse Both
Acetylsalicylic acid 100 mg tablet 84.8% 100.0% 87.5%
Amoxicillin 500 mg caps. 78.8% 94.1% 86.7%
Amoxicillin Powder 50 mg/ml susp. 81.8% 94.1% 90.0%
Benzathine benzylpenicillin 1.200.000UI 60.6% 94.1% 66.7%
Cimetidine 200 mg tablet 66.7% 76.5% 91.7%
Diazepam 10 mg tablet 60.6% 100.0% 62.5%
Erythromycin 250 mg tablet 78.8% 88.2% 92.9%
Erythromycin 25 mg/ml susp. 66.7% 82.4% 84.6%
Glibenclamide 5 mg tablet 84.8% 100.0% 87.5%
Hydrochlorothiazide 50 mg tablet 63.6% 76.5% 84.0%
Imipramine 25 mg coated tablet 60.6% 88.2% 69.0%
Mebendazole 20 mg/ml susp. 66.7% 76.5% 91.7%
Metronidazole 250 mg tablet 84.8% 94.1% 93.3%
Paracetamol 500 mg tablet 57.6% 64.7% 95.0%
Propranolol 40 mg tablet 69.7% 88.2% 79.3%
Oral rehydration salts powder envelope 81.8% 94.1% 90.0%
Salbutamol 0.4 mg/ml sol. Oral 81.8% 94.1% 90.0%
Sulphamet. + Trimet. 400 + 80 mg , tablet 87.9% 100.0% 90.6%
Sulphamet. + Trimethoprim 4%+ 0.8 susp. 78.8% 88.2% 92.9%
Ferrous sulphate 25mg Fe/ml oral sol. 78.8% 94.1% 86.7%
Mean availability 74% 89% 83%
Evaluation of pharmaceutical assistance in municipalities in the state of Minas Gerais 285
budgets for drugs purchase. However, it is important to 
notice the existence of municipalities where no acquisition 
was done by bidding, or in which only 33% of resources 
were effectively spent with drug, with respect to indebted 
expenses.
Some components of PA chain have demonstrated 
weak performance. The inventory control in the local 
distribution center, for instance, was revealed inefficient, 
since in many cases the actual stock count did not match 
the inventory control. That could be explained by the fact 
that the distribution to the US took place in a moment ear-
lier to the count process done, or even during such process, 
without the update in the inventory control. However, 
considering that the update in the stock control system 
should occur in the exact moment they are put in effect, 
these discordances do not attenuate the weak performance 
of evaluated system control. This inefficiency raises con-
cerns, given the characteristic of PA organization, in which 
different components determine themselves mutually in 
a chain process (Perini, 2003), so the lack of inventory 
control could influence negatively the acquisition and 
programming process.
Regarding the drug availability in the health faci-
lities, the low presence of imipramine and benzathine 
benzylpenicillin is justified by the fact that in many 
municipalities, drugs with central nervous system action 
or injectable drugs as well were only made available in 
some US. The low availability in the local distribution 
center of cimetidine 200 mg and hydrochlorothiazide 50 
mg (both with 77%) could be explained by the fact that 
these drugs were recently replaced by other, in the State 
Essential Drug List.
The causes of non-supplying in the US, of drugs 
that were found in the distribution center, were not inves-
tigated; however, two situations observed during the data 
collection could explain this fact: the termination of the 
US stock before the next distribution, and the coincidence 
between the collection data moment and the drug arrival 
to municipal distribution center. Anyway, both situations 
characterize planning problems in the system supplying 
chain. Further investigation could evaluate the number of 
non-supplying days of a given drug in the US, and compare 
this value to the number of non-supplying days of the same 
drug in the distribution center.
The discussion about quality improvements in the 
basic healthcare drives, directly or indirectly, to the notion 
of evaluation. The evaluation area of programs, services, 
interventions and technologies in the health area passes 
through the outgrowth and diversification of concepts and 
methods, in order to enable the construction of a tool to 
support the implementation of public policies (Novaes, 
2000). In the public sector, there is a higher interest on 
the development of evaluations programs with emphasis 
in quality or in cost-effectiveness. The consolidation of 
SUS requires more and more the application of evalu-
ation methods and the utilization of indicators for this 
purpose allow the establishment of standards, as well as 
the following-up of their evolution along the years. The 
responsible sectors for PA organization should reinforce 
their actuation in this sense.
This work allowed the recognition of some essential 
aspects of organization and functioning of pharmaceutical 
assistance, within a GRS of Minas Gerais. The initiative 
should be considered as a starting point for the construc-
tion of more refined instruments, being respected the 
balance between the necessity of deeper evaluations and 
the simplicity of indicators relationship, instruments and 
collection process for their routine application, or appli-
cation at determined periodicity, for system monitoring. 
CONCLUSIONS
The procedures to evaluate pharmaceutical assis-
tance adopted in this work showed to be feasible at the 
municipal level. The data have pointed out: (a) that US de-
prived of items that were available in the local distribution 
center, apparently, represents a fragility in the distribution 
strategies and stock control, demonstrating the need for 
mechanisms to manage them; (b) the advancements in 
the effectiveness of important steps for the evolution of 
the whole system, such as the elaboration and updating 
of Municipal Essential Drug List and the mechanisms of 
acquisition, suggest that the efforts for reorientation of 
pharmaceutical assistance, which include the pharma-
cists enabling and valorization, begin to produce positive 
results. 
The impact of these results over the user healthcare 
and the efficiency of drugs expenses are now challenges 
to be faced, besides the establishment of a systematic 
monitoring process for routinely admeasurements of its 
functioning.
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